Liver Fibrosis Treatment Market is Estimated to Grow at a CAGR of 10.9% within the forecast period of 2023-2030: Cognitive Market Research

Global Liver Fibrosis Treatment Market Overview:
Liver fibrosis is the development of abnormally large amounts of scar tissue in the liver as a result of repeated or continuous liver injury. Fibrosis has asymptomatic but excessive scarring develops cirrhosis, which has symptoms. The severity of the disease is checked by blood and imaging tests, as well as liver biopsy, by medical professionals. Healthcare professionals concentrate on treating the underlying cause of liver fibrosis since this frequently prevents or slows the progression of liver scarring and improves outcomes.

Summary:
• As per the study of CMR, The Global Liver Fibrosis Treatment market is estimated to be valued at USD 14.8 billion in 2022 and is expected to exhibit a CAGR of 10.9% during the forecast period (2022-2030).
• North America dominates the global liver fibrosis treatment market with the highest revenue share
• The hospital has the largest revenue share for the growth of the global liver fibrosis treatment market
• The chronic liver diseases segment is forecasted to dominate the global liver fibrosis treatment market

To know more about The Liver Fibrosis Treatment Market statistics click here: https://www.cognitivemarketresearch.com/liver-fibrosis-treatment-market-report

Global Liver Fibrosis Treatment Market Drivers:
The rising prevalence of liver fibrosis across the globe is forecasted to dominate the global liver fibrosis treatment market. In addition, growing healthcare expenditure by increasing funding drives the demand for the global market. Furthermore, growth in the number of research and development activities will provide the opportunity for the growth of the global market.
However, the high cost associated with the treatment and the lack of healthcare infrastructure in emerging economies may hamper the growth of the global liver fibrosis treatment market.

Market Segmentation:
Treatment Type:
• ACE Inhibitors
• Hepatotropic Drug
• Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist
• Others
By treatment type, the hepatotropic drug segment has the largest revenue share in the global liver fibrosis treatment market. This is attributed to it enabling efficient and safe treatment for reducing fibrosis in patients.

Condition:
• Chronic Liver Diseases
• Hepatitis C
• Nonalcoholic Steatohepatitis
By condition, the global market is segmented into chronic liver diseases, hepatitis C, and nonalcoholic steatohepatitis. The chronic liver diseases segment is forecasted to dominate the global market, due to the increasing prevalence of chronic liver diseases across the globe.

Distribution Channel:
• Hospitals
• Specialty Clinics
• Others
The hospital has the largest revenue share for the growth of the global market, due to hospitals being well-equipped with diagnostic testing devices.

Competitive Analysis of Liver Fibrosis Treatment Market: ABBVIE INC, GILEAD SCIENCES INC, MERCK & CO. INC, VIATRIS INC, ABBOTT LABORATORIES, ASTELLAS PHARMA INC, BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, F. HOFFMANN-LA ROCHE AG, EMERGENT BIOSOLUTIONS INC. (CANGENE BIOPHARMA)

Get free sample pages of the latest published Liver Fibrosis Treatment Market Report: https://www.cognitivemarketresearch.com/liver-fibrosis-treatment-market-report

North America has the largest revenue share in the global liver fibrosis treatment
North America dominates the global liver fibrosis treatment market with the highest revenue share. This is attributed to the increase in the consumption of alcohol, and unhealthy lifestyles leading to weight gain and obesity that dominate the global market Furthermore, Asia Pacific is forecasted to dominate the global market in terms of growth rate. The increasing level of investment by the government for the improvement of healthcare organizations and the rising prevalence of liver disorders in the country in the region.

Global Liver Fibrosis Treatment Market Recent News
Siemens Healthineers announced the launch of the Enhanced Liver Fibrosis (ELF) Test in the U.S
In January 2022, Siemens Healthineers introduced the announcement of the ELF (Enhanced Liver Fibrosis) Test in the United State. This test provides broad clinical access to the minimally invasive prognostic device. The enhanced liver fibrosis test is a simple, effective blood test for evaluating prognosis in individuals with advanced fibrosis (F3 or F4) caused by non-alcoholic steatohepatitis (NASH), a kind of non-alcoholic fatty liver disease (NAFLD) considered by liver inflammation.

Browse Here For Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Liver Fibrosis Treatment Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Liver Fibrosis Treatment Market Segmentation
1.5.1 Liver Fibrosis Treatment Market Regional Fragmentation
1.5.1 Liver Fibrosis Treatment Market Players
• 1.6 Report Duration
• 1.7 List of Stakeholders
Chapter 2 Research MethodologyReview Complete Research Methodology
Chapter 3 Executive Summary of Liver Fibrosis Treatment Market
• 3.1 Global Liver Fibrosis Treatment Market Size 2018 - 2030, (USD Million)
• 3.2 Global Liver Fibrosis Treatment Value, Absolute & Opportunity Analysis
• 3.3 Global Liver Fibrosis Treatment Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
• 3.4 Global Liver Fibrosis Treatment Market Statistics 2022: Snapshot
Chapter 4 Global Liver Fibrosis Treatment Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Environmental, Social, and Governance (ESG) Analysis
Chapter 7 Qualitative Analysis
Chapter 8 Company Profiling (Subject to Availability)
Chapter 9 Global Liver Fibrosis Treatment Market by Treatment Type Segmentation Analysis (2018-2030)
Chapter 10 Global Liver Fibrosis Treatment Market by Condition Segmentation Analysis (2018-2030)
Chapter 11 Global Liver Fibrosis Treatment Market by Distribution Channel Segmentation Analysis (2018-2030)
Chapter 12 Global Liver Fibrosis Treatment Market Regional Analysis
Chapter 13 North America Liver Fibrosis Treatment Market Outlook (2018 - 2030)
Chapter 14 Europe Liver Fibrosis Treatment Market Outlook (2018 - 2030)
Chapter 15 Asia Pacific Liver Fibrosis Treatment Market Outlook (2018 - 2030)
Chapter 16 Latin America Liver Fibrosis Treatment Market Outlook (2018 - 2030)
Chapter 17 Middle East and Africa Liver Fibrosis Treatment Market Outlook (2018 - 2030)
Chapter 18 Research Findings
Customize the Report Edition (Is applicable, On Request, Subject to Data Available, At an Additional Cost)
To know more about The Liver Fibrosis Treatment Market TOC click here: https://www.cognitivemarketresearch.com/liver-fibrosis-treatment-market-report#table_of_contents

Related Report:
• Liver Failure Therapeutics Market- https://www.cognitivemarketresearch.com/liver-failure-therapeutics-market-report
• Liver Diseases Therapeutics Drugs Market- https://www.cognitivemarketresearch.com/liver-diseases-therapeutics-drugs-market-report
• Liver Disease Treatment Market- https://www.cognitivemarketresearch.com/liver-disease-treatment-market-report
• Liver Health Supplements Market- https://www.cognitivemarketresearch.com/liver-health-supplements-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.